Absence of Cross-Presenting Cells in the Salivary Gland and Viral Immune Evasion Confine Cytomegalovirus Immune Control to Effector CD4 T Cells by Walton, Senta M. et al.
Absence of Cross-Presenting Cells in the Salivary Gland
and Viral Immune Evasion Confine Cytomegalovirus
Immune Control to Effector CD4 T Cells
Senta M. Walton
1, Sanja Mandaric
1, Nicole Torti
1, Albert Zimmermann
2, Hartmut Hengel
2, Annette
Oxenius
1*
1Institute of Microbiology, ETH Zu ¨rich, Zu ¨rich, Switzerland, 2Institute for Virology, Heinrich-Heine-University Du ¨sseldorf , Du ¨sseldorf, Germany
Abstract
Horizontal transmission of cytomegaloviruses (CMV) occurs via prolonged excretion from mucosal surfaces. We used murine
CMV (MCMV) infection to investigate the mechanisms of immune control in secretory organs. CD4 T cells were crucial to
cease MCMV replication in the salivary gland (SG) via direct secretion of IFNc that initiated antiviral signaling on non-
hematopoietic cells. In contrast, CD4 T cell helper functions for CD8 T cells or B cells were dispensable. Despite SG-resident
MCMV-specific CD8 T cells being able to produce IFNc, the absence of MHC class I molecules on infected acinar glandular
epithelial cells due to viral immune evasion, and the paucity of cross-presenting antigen presenting cells (APCs) prevented
their local activation. Thus, local activation of MCMV-specific T cells is confined to the CD4 subset due to exclusive
presentation of MCMV-derived antigens by MHC class II molecules on bystander APCs, resulting in IFNc secretion interfering
with viral replication in cells of non-hematopoietic origin.
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Introduction
Cytomegaloviruses (CMVs), members of the b-herpesvirus
family, establish a latent persistent infection. Although primary
infection in immune-competent individuals is in general clinically
silent, severe complications caused by reactivation or primary
infection are frequent in immune-compromised patients such
as transplant recipients or HIV patients. However, even in
individuals with a competent immune system, CMV is detectable
in mucosal secretions for a long period after primary encounter,
representing the main source for both horizontal and vertical
transmission [1]. As sustained replication and shedding of CMVs
by the salivary gland (SG) into the saliva is one of the prime
reasons for primary and secondary CMV infection (reviewed in
[2,3]), in addition to transmission via breast milk and genital
secretions, it is of particular interest for the virus to evade its
immune recognition in the SG. Prolonged shedding of CMV into
the saliva is also observed in murine CMV infection (MCMV),
rendering it a valuable model to identify mechanisms of how
CMVs are controlled in the SG [4]. On the host side, specific
immune mechanisms are required to control viral replication in
the SG: Depletion of CD4 T cells abolished viral control in the SG
with sustained viral replication up to 10 weeks post infection [5].
Sustained MCMV replication is restricted in the SG to a particular
cell subset, the acinar glandular epithelial cells (AGECs). As
systemic neutralization of IFNc and TNFa abolished antiviral
MCMV control in the SG, it was proposed, but never directly
proven, that CD4 T cells control viral replication via secretion of
IFNc and TNFa [6,7]. MCMV-specific CD4 T cells were indeed
found to produce both of these cytokines [8,9], but it remains
unclear whether CD4 T cells directly control MCMV replication
via secretion of IFNc and TNFa. Further, although never directly
addressed experimentally, it was proposed that IFNc secreted by
virus-specific CD4 T cells may act on other immune cells such as
NK cells to induce antiviral activities in these secondary effector
cells and not directly on infected target cells [4]. In contrast to
CD4 T cells, CD8 T cells and B cells seem to be dispensable for
MCMV control in the SG [10,11,12].
Many open questions remain as to why CD4 T cells are so
crucial to control MCMV in the SG and not - or to a lesser extent
– in other tissues. Up to date it is unclear whether CD4 T cells are
necessary to support the recruitment or function of other immune
cell subsets in the SG during MCMV infection, as immune
responses to MCMV have not been investigated comprehensively
in this relevant tissue. To investigate in detail local immune control
of MCMV replication in the SG, we identified the exact
mechanisms of antiviral control exerted by CD4 T cells. We
prove that production of IFNc by CD4 T cells is essential to
control MCMV replication and IFNc needs to be sensed by radio-
resistant cells and not by cells of the hematopoietic lineage. Despite
being able to secrete IFNc and outnumbering MCMV-specific
CD4 T cells, MCMV-specific CD8 T cells are unable to control
MCMV replication in the SG due to extensive virus-induced
down-regulation of MHC molecules on infected AGECs. Hence,
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having taken up and processed exogenous MCMV-derived
antigens. Intriguingly, SG-resident APCs are unable to cross-
present particulate antigens, resulting in severe paucity of MHC
class I but largely intact MHC class II presentation of MCMV-
derived epitopes on these APCs. Thereby MCMV efficiently
evades its immune recognition and elimination by CD8 T cells,
ensuring prolonged viral shedding into the saliva and promoting
horizontal transmission.
Results
Helper functions exerted by CD4 T cells are dispensable
for control of MCMV infection in the SG
CD4 T cells are crucial to control MCMV infection, especially
in the SG where productive viral replication continues in the
absence of these cells, at least for 10 weeks which was the longest
observation period in previous studies [5,6]. We corroborated this
finding and extended the observation period to more than one
year, by comparing viral titers of two mouse strains that lack CD4
T cells, namely MHC class II knockout (MHCII
-/-) and CD4
knockout mice (CD4
-/-), with wild type C57BL/6 (B6) mice at
different stages post MCMV-Dm157 (herein after referred to
MCMV) infection. m157 is expressed on the surface of MCMV-
infected host cells and interacts with the activating receptor Ly49H
on NK cells of B6 mice, thereby leading to enhanced viral control.
We deliberately used an m157 deletion mutant in our studies as
most laboratory mouse strains as well as tested outbred mice lack
expression of Ly49H [13,14]. Using plaque forming assays,
presence of replicating MCMV was analyzed in several organs
including the spleen, lung, liver and SG over more than one year.
In the absence of CD4 T cells, increased viral titers and prolonged
detection of replicating virus was observed for all organs
examined. However, with the striking exception of the SG,
infectious virus was eventually controlled in spleen, liver and lung
(Fig. S1). In the SG infectious MCMV was still detectable in
MHCII
-/- mice, even more than one year post infection (Fig. 1A).
Surprisingly, in CD4
-/- mice, MCMV replication in the SG was
eventually controlled between 200 to 400 days post infection.
CD4 T cells can control pathogens by several means, a
prominent function being provision of help to either CD8 T cells
or B cells which then control pathogen replication via cytotoxicity
or production of antibodies. To test if CD4 T cells control MCMV
by exerting helper mechanisms, we analyzed virus titers of
MCMV infected CD8 T cell (CD8
-/-) and B cell deficient mice
(JHT mice). SG virus titers in both of these mouse strains were
comparable to wild type animals at four (Fig. S2A) and eight (Fig.
S2B) weeks post infection; at both time points, however, viral titers
were markedly increased in MHCII
-/- mice. Our results are
consistent with previous reports of efficient viral control in the
absence of CD8 T cells and B cells [10,11,12]. It is possible,
however, that MCMV-specific CD8 T cell responses were
impaired in the SG of CD4 T deficient animals, leading to
impaired viral control. This would be a plausible explanation for
the requirement of CD4 T cells to control MCMV replication in
the SG which has not been addressed so far. To exclude a role of
T cell help for CD8 T cells in the SG, we analyzed CD8 T cell
responses in CD4 T cell deficient and control B6 mice (Fig. 1B-E).
SG-resident lymphocytes were isolated and CD8 T cells specific
for the epitopes M45 (Fig. 1B, D) and M38 (Fig. 1C, E) were
quantified by tetramer staining. M45-specific CD8 T cell
responses in mice lacking CD4 T cells were largely comparable
to wild type mice and M38-specific CD8 T cell responses were
generally increased in MHCII
-/- and CD4
-/- mice, indicating that
MCMV-specific CD8 T cell responses in the SG were not
impaired in absence of CD4 T cells up to 120 days post infection.
CD4 T cells control MCMV replication by secretion of IFNc
Previous studies indicated that systemic administration of
neutralizing antibodies specific for either IFNc or TNFa could
abolish CD4 T cell-mediated control of MCMV replication in
adoptive transfer models [6,7]. Further, in CMV-seropositive
humans, direct cytolytic activity exerted by virus-specific CD4 T
cells was proposed [15]. Although IFNc and TNFa are involved in
the control mechanisms exerted by CD4 T cells, it remains
unknown if CD4 T cells produce these cytokines themselves and
which cell type these mediators act upon. To identify the effector
molecules produced directly by CD4 T cells to control SG MCMV
replication, we generated the following mixed bone marrow
chimeras: CD4
-/- recipients were c-irradiated and reconstituted
with 50% bone marrow of CD4
-/- and 50% bone marrow of either
IFNc deficient (IFNc
-/-), TNFa-deficient (TNFa
-/-), perforin-
deficient (PKOB), CD4
-/- or B6 mice. By doing so, CD4 T cells
present in the reconstituted animals were the only cell subset being
entirely deficient for either IFNc (IFNc
-/-xCD4
-/-), TNFa
(TNFa
-/-xCD4
-/-) or perforin (PKOBxCD4
-/-). Control animals
lacked CD4 T cells completely (CD4
-/-xCD4
-/-) or CD4 T cells
were fully functional (B6xCD4
-/-). At the time point of infection,
frequencies of CD4 T cells were comparable in all experimental
groups harboring CD4 T cells (data not shown). The chimeric
mice were infected with a recombinant MCMV expressing the
firefly luciferase under the control of the m157 promoter [16]. In
these animals active viral replication is detectable by in vivo
bioluminescence imaging after intraperitoneal administration of
D-luciferin (Fig. 2A). Furthermore, two to four months post
infection MCMV titers were determined in the SG by plaque
assay. Percentages of non-controllers (viral titer above detection
limit) and the viral titers are shown in Fig. 2B and C. Viral control
was impaired in (CD4
-/-xCD4
-/-) compared to (B6xCD4
-/-)
chimeras, corroborating our results in non-chimeric mice. While
a comparable lack of MCMV control was observed in mice in
Author Summary
Cytomegaloviruses (CMVs) infect 50 to 90 % of the world’s
population and cause severe clinical complication in
immunosuppressed individuals. An important tissue for
horizontal transmission is the salivary gland (SG). CD4 T
cells are crucial for viral control in this organ. However,
how CD4 T cells control MCMV and why CD8 T cells,
important effector cells in other organs, are inefficient in
the SG, remains unclear. Here we show that CD4 T cells
exert direct antiviral effector rather than helper functions
by secretion of IFNc acting on non-hematopoietic cells.
Although SG-resident CD8 T cells were able to produce
IFNc and outnumbered CD4 T cells, absence of MHC class I
expression on infected cells due to CMV-encoded immune
evasion genes and concomitant absence of cross-present-
ing antigen presenting cells prohibited antigen recogni-
tion by CD8 T cells. Deletion of CMV-encoded immune
evasion genes enabled CD8 T cells to control MCMV
replication in the SG in absence of CD4 T cells. Hence, CMV
control depends on direct antiviral functions of CD4 T cells
because of exclusive MHC class II-restricted CMV antigen
presentation by bystander APCs in the SG, exemplifying a
strategy of effective immune evasion by which CMVs to
promote their own transmission.
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CD4 T cells were completely absent, MCMV replication was
similarly controlled in the SG of chimeric mice in which CD4 T
cells lacked TNFa or perforin and in mice with fully functional
CD4 T cells. To exclude impaired CD4 T cell priming in any
of the experimental groups, frequencies of lung-derived MCMV-
specific CD4 T cells secreting IFNc or TNFa were analyzed
and were comparable in all CD4-sufficient animals (data not
shown). These data strongly support the notion that CD4 T cells
directly control MCMV replication in the SG by secretion of
IFNc.
Next, we addressed the question whether IFNc secreted by CD4
T cells inhibited viral replication in the SG by signaling via IFNc
receptors (IFNcR) expressed on non-hematopoietic cells (including
infected AGECs) or by triggering IFNcR signaling on hemato-
poietic cells, thereby stimulating other immune cells such as NK
cells to control viral replication. Using either IFNcR
-/- or wild type
mice as recipients or donors, bone marrow chimeras were
Figure 1. Helper functions exerted by CD4 T cells are dispensable for MCMV control. (A) MCMV titers in the SG in CD4
-/- (open triangles),
MHCII
-/- (open circles) and B6 (closed circles) mice at different time points post infection. Dotted line shows detection limit. (B–E) M45- and M38-
specific CD8 T cells were quantified by tetramer staining of pooled SG leukocytes of CD4
-/- (open triangles), MHCII
-/- (open circles) and B6 (closed
circles) mice at different time points post MCMV infection. Representative results of three independent experiments are shown.
doi:10.1371/journal.ppat.1002214.g001
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-/- R
IFNcR
-/-), that lacked IFNcR on radio-resistant cells (B6 R
IFNcR
-/-), that lacked IFNcR on radio-sensitive cells (IFNcR
-/- R
B6) or that expressed IFNcR on all cells (B6 R B6). 8 weeks post
MCMV infection, viral titers increased in the SG when IFNcR
was completely absent compared to wild type counterparts
(Fig. 2D). Importantly, increased lytic viral replication was only
observed in mice which either completely lacked IFNcR
expression or selectively on non-hematopoietic cells. In contrast,
mice that lacked IFNcR only on hematopoietic cells controlled
MCMV replication. 8 weeks post infection, MCMV-specific
CD4 T cell responses were comparable between experi-
mental groups (data not shown). Hence, IFNc secreted by CD4
T cells signaled on radio-resistant cells to suppress viral
replication.
IFNc-secreting CD8 T cells outnumber IFNc-producing
CD4 T cells in the SG and are abundantly present in the
absence of CD4 T cells
CD8 T cells and NK cells from the spleen were shown to
produce IFNc upon MCMV infection [17,18]. Why is then
exclusively IFNc produced by CD4 T cells so crucial to control
viral replication in the SG? We first tested if IFNc production by
MCMV-specific CD8 T cells isolated from the SG was impaired.
Numbers of CD8 T cells secreting IFNc after ex vivo restimulation
Figure 2. CD4 T cells exert direct antiviral mechanisms by secretion of IFNc. (A) c-irradiated CD4
-/- were reconstituted with 50% bone
marrow of CD4
-/- mice and 50% bone marrow of either CD4
-/-, IFNc
-/-, TNFa
-/-, PKOB or B6 mice. Mice were infected with a MCMV mutant expressing
the firefly luciferase under the control of the m157 promoter. 10 minutes prior to analysis, D-luciferin was injected i.p. and active virus replication was
detected by in vivo bioluminescence imaging in one month infected chimeras. (B, C) 2 to 4 months post infection viral titers were determined by
plaque assay. Dotted line shows detection limit. Combined results of three individual experiments are shown. Percentages of mice bearing a virus
load above the detection limit (non-controllers) are indicated in B and the virus titers are shown in C. (D) IFNcR
-/- or B6 mice were c-irradiated and
reconstituted with of B6 or IFNcR
-/- bone marrow, respectively. MCMV titers in the SG were determined 8 weeks post infection. Representative results
of two independent experiments are shown. (* p,0.05, ** p,0.01, *** p,0.001, 2-tailed unpaired student’s t-test).
doi:10.1371/journal.ppat.1002214.g002
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any time point examined (Fig. 3A), indicating that MCMV-specific
CD8 T cells per se were able to produce IFNc.
CD4 T cells were shown to be necessary for the development of
fully functional CD8 T cells in a variety of infection models
(reviewed by [19]). Although the absence of CD4 T cells only
slightly impacted the functionality of CD8 T cells isolated from the
spleen, lung or liver [5,20,21,22], the possibility remained that SG
derived MCMV-specific CD8 T cell function was crucially
dependent on CD4 T cells. However, in the SG, IFNc-producing
CD8 T cells specific for either the M45 or the M38 epitope were
increased rather than decreased in the absence of CD4 T cells at
various time points post MCMV infection (Fig. 3B). Even IE3-
specific CD8 T cell responses, which have previously been shown
in the blood and spleen to largely depend on presence of CD4 T
cells [22], were detected to almost comparable levels in the SG in
presence or absence of CD4 T cells. These data clearly argue
against a role for CD4 T cells to support CD8 T cell function in
the SG at the investigated time points.
CD8 T cells as well as NK cells infiltrate the SG and
migrate to infected cells in the absence of CD4 T cells
Although MCMV-specific CD8 T cells and NK cells were
detectable in the SG tissue by flow cytometric analysis, their
migration to close proximity of infected cells might be less efficient
in comparison to MCMV-specific CD4 T cells. To determine the
homing and tissue distribution of CD8 T cells and NK cells in
relation to MCMV-infected cells, we performed confocal immu-
nofluorescence analyses on tissue sections of the SG. B6 and
MHCII
-/- mice were infected with a GFP-expressing m157-
deficient MCMV mutant. Three weeks later SG sections were
stained for CD4 T cells, CD8 T cells, NK cells, B cells and CD11b
as well as CD11c expressing cells (Fig. 4 and Fig. S3). As shown
Figure 3. MCMV-specific CD8 T cells isolated from the SG secrete IFNc. (A) Kinetic analysis of the number of IFNc-secreting CD8 T cells after
ex vivo restimulation with the epitopes M45 (closed squares) and M38 (closed triangles) or CD4 T cells after stimulation with a lysate of MCMV
infected cells (open circle) in the SG. B) Total numbers of IFNc-producing CD8 T cells isolated from SG of wild type (black bars) or MHCII
-/- (open bars)
mice after ex vivo restimulation with either M45, M38 or IE3 peptides after 2, 8 or 16 weeks post infection. Data of SGs pooled from three to four mice
per group are displayed.
doi:10.1371/journal.ppat.1002214.g003
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infected with MCMV at this time point and displayed cell
enlargement typical for MCMV infected cells (Fig. 4). Scattered
throughout the SG tissue, dense foci of leukocyte infiltrates were
detectable comprising not only CD4 and CD8 T cells but
also CD11c and CD11b expressing as well as NK and B cells.
However, these dense foci of leukocytes most often did not contain
GFP
+ cells (Fig. 4 and Fig. S3; right columns). We propose that
these infiltrates had previously surrounded a GFP-positive
MCMV-infected cell that had been eliminated and is hence no
longer detectable via GFP expression. GFP-expressing (hence
MCMV infected) AGECs were either located distal, proximal or
in very rare occasions within leukocyte infiltrates. Only few
immune cells were in close proximity to infected cells when
situated distal to infiltrates (Figs. 4A, B and Fig. S3; left columns).
Interestingly, in some infiltrates, cells displaying a lower GFP
fluorescence intensity were detected which exhibited a much
smaller cell size than GFP-expressing AGECs. Furthermore, their
morphology was comparable to the surrounding cells of the
infiltrate, suggesting that these cells were not directly infected cells
but might rather be phagocytic cells which had taken up remnants
of MCMV infected cells including GFP (Fig.4, middle column).
Figure 4. CD4 as well as CD8 T cells infiltrate the infected SG tissue and CD8 T cell infiltration is CD4 T cell independent. SGs were
isolated three weeks post infection from B6 (A and B) or MHCII
-/- (C) mice infected with a GFP-expressing MCMV mutant. Cryosections of SG were
counterstained with anti-CD4 (A; red) or anti-CD8 (B and C; red) and anti-CD11c (blue). MCMV-bearing AGECs (green) were situated either distal to
immune infiltrates (left column) or in proximity to infiltrates (middle columns). In some infiltrates cells with very low fluorescent intensity for GFP were
present (middle column; arrow), most likely representing cells not directly infected with MCMV but instead cells that had taken up remnants of
MCMV-infected cells. Dense leukocyte infiltrates were often devoid of GFP
+ cells (right column). Confocal images were taken with 20 times
magnification. Scale bar indicates 100 mm. One representative picture of a minimum of 10 is shown.
doi:10.1371/journal.ppat.1002214.g004
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necessary for the migration of herpes simplex virus-specific CD8 T
cells tothesite ofinfection [24]. However, duringMCMV infection,
migration of CD8 T cells, B cells as well as NK cells, CD11c and
CD11b expressing cells to infected cells of the SG was not impaired
in the absence of CD4 T cells (Fig. 4C and Figs. S3 and S4).
Distribution of these cells in the SG examined by immunohistolog-
ical analysis were comparable between MCMV-infected MHCII
-/-
and B6 mice with the only exception that the former strain had
increased numbers of infected foci (Fig. 4C and Fig. S3).
MHC class I and II expression is only detectable on very
few infected cells of the SG and only at very low levels
We hypothesized that CD8 T cells, in contrast to CD4 T cells,
are unable to control viral replication in the SG because they are
not exposed to their cognate antigen in this particular organ.
MCMV suppresses not only MHC class I but also MHC class II
expression on infected cells [25,26,27,28] and inhibition of MHC
class I expression might be more pronounced in AGECs than
MHC class II expression. To test this hypothesis, sections of SG
were stained for MHC class I and II expression three weeks post
MCMV-GFP infection and analyzed by confocal microscopy.
Neither MHC class I nor MHC class II molecules were detectable
on directly infected GFP-positive cells when distal to cell infiltrates
(Fig. 5A and D). However, once proximate to leukocyte infiltrates,
very few infected cells expressed very low levels of MHC class I
and class II on their cell surface, but to a much lower extent than
on the close-by leukocyte infiltrate (Fig. 5B and E). Overall, 86%
of all GFP-infected cells had no detectable surface expression of
MHC class I and only 14% expressed MHC class I at very low
levels. Comparably, only 14% of GFP-expressing cells in the SG
were slightly positive for MHC class II on their cell surface. Low or
absent MHC expression on directly infected cells stands in line
with published data showing that MCMV very potently inhibits
antigen presentation via down-regulation of MHC molecules in
vitro [25,26,27,28,29]. MHC class I expression on uninfected
AGECs was concentrated to the apical side of the cells and was
overall low in comparison to leukocytes (Fig. 5C). MHC class II
expression was completely absent in uninfected AGECs (data not
shown). The comparably rare and low expression patterns of
MHC class I and II by infected AGECs argues against the
hypothesis that CD4 T cells would preferentially interact directly
with MCMV-infected AGECs.
SG resident APCs are deficient in cross-presentation
Although directly infected cells of the SG lacked MHC class I
and II expression, other cells present in close proximity expressed
high levels of both these molecules (Fig. 5). It is likely that these
non-infected bystander APCs are presenting MCMV-derived
antigens to MCMV-specific T cells. As these bystander cells were
clearly not directly infected since they lacked GFP expression,
these cells would have to present MCMV antigens from an
exogenous source. It is conceivable that MHC class II-restricted
MCMV epitopes might be presented on these APCs much more
efficiently than MHC class I-restricted epitopes. In the spleen,
cross-presentation of exogenous antigens on MHC class I
molecules is largely restricted to a distinct dendritic cell (DC)
subset, identified by CD11c, MHCII, CD8a, DEC205 expression
and concomitant absence of B220 and CD4 expression [30].
To test if SG-resident APCs are phenotypically related to cross-
presenting splenic DCs, splenic DCs as well as SG-derived APCs
were stained for surface expression of CD11c, MHC class II,
B220, DEC205, CD4, and CD8a at different time points post
infection. CD11c
+, MHCII
+, CD8a
+, DEC205
+, B220
2, CD4
2
cross-presenting DCs were detectable in the spleen of B6 mice at
all the time points examined (Fig. 6A and B). In contrast, this DC
subset was almost completely absent in the SG isolated from naı ¨ve
animals (Fig. 6A). Even when the SG tissue was heavily infected by
MCMV two and four weeks post infection, frequencies of CD11c
+,
MHCII
+, CD8a
+, DEC205
+, B220
2, CD4
2 cells among the
overall SG-resident APC population remained very low (,1.5%)
and total numbers remained far below their splenic counterparts.
In peripheral organs such as the gastrointestinal tract, skin and the
lung CD103
+ DCs represent one of the major DC subset able to
cross-present exogenous antigen to CD8 T cells [31,32] and on
day 28 30% of the SG-resident CD11c
+ I-A
b+ APCs expressed
CD103 on their cell surface (Fig. 6 A).
To formally assess the capacity of SG-resident APCs to process
and present exogenous antigen on MHC class I or class II
molecules, we isolated SG-resident APCs and splenic DCs. APCs
were left untreated or were pulsed with virus like particles (VLPs)
linked either to the LCMV-derived MHC class I-restricted epitope
gp33 or the MHC class II-restricted gp61 epitope. As controls,
APCs were pulsed directly with the respective peptides. We used
VLPs to assess cross-presentation capacities of splenic DCs and
SG-derived APCs as they represent a well-characterized particu-
late antigen which has been previously shown to depend on cross-
presentation for MHC class I antigen loading using splenic DCs
[33]. Identical numbers of spleen- or SG-derived APCs were then
added to naı ¨ve CFSE-labeled TCR transgenic CD8 T cells
recognizing the gp33 epitope (P14 cells) or TCR transgenic CD4
T cells specific for the gp61 epitope (Smarta cells). P14 cells
recognized their antigen on splenic DCs either pulsed with VLP-
gp33 or their cognate peptide (Fig. 6C). However, salivary gland-
derived APCs were not able to cross-present the cognate peptide to
P14 T cells when pulsed with VLP-gp33. SG-derived APCs were
not per se unable to stimulate CD8 T cells as they were able to do
so when pulsed with the gp33 peptide. In contrast, Smarta cells
proliferated extensively when incubated with either SG-derived
APCs or splenic DCs pulsed with VLP-gp61. These results
demonstrate, on a functional level, that SG-resident APCs are not
able to cross-present exogenous antigens to CD8 T cells. As we
could never detect GFP
+ CD11c
+ cells in any of the SG sections
analyzed, we conclude that they are not directly infected by
MCMV and hence do not present endogenous MCMV-derived
antigens on MHC class I molecules. However, in line with the
notion that SG-resident APCs are responsible for MCMV antigen
presentation, we were able to detect in some rare cases CD11c
+
MHC class I (Fig. S5A) or MHC class II (Fig, S5B) expressing cells
with focal GFP inclusions which most likely represent APCs which
had phagocytosed remnants of infected AGECs. Based on our
functional in vitro data, we propose that these might be the very
cells being responsible for local MCMV-derived antigen presen-
tation to CD4 T cells.
MCMV lacking MHC class I immune evasion genes is
controlled in the SG in absence of CD4 T cells
To directly assess whether the absent MHC class I expression
on infected AGECs due to MCMV-encoded immune evasion
genes was responsible for the exclusive CD4 T cell-mediated
control of MCMV in the SG, we made use of a triple MCMV
mutant lacking all three major MHC class I immune evasion genes
m04, m06 and m152 (Dm04Dm06Dm152) [34]. B6, CD4
-/- and
MHCII
-/- mice were infected with Dm04Dm06Dm152 MCMV and
its parental BAC-derived virus and viral titers were examined 28
days post infection in the SG. While MHCII
-/- and CD4
-/- mice
were unable to control wild type (WT) MCMV replication, they
were able to control Dm04Dm06Dm152 MCMV by day 28 post
CD4 T Cell Control of Salivary Gland CMV Infection
PLoS Pathogens | www.plospathogens.org 7 August 2011 | Volume 7 | Issue 8 | e1002214Figure 5. MHC class I and II expression is absent in intact MCMV infected cells and may be re-expressed at low levels on infected
cells in proximity to leukocyte infiltrates. Three weeks post MCMV-GFP infection, SG sections isolated from B6 mice were stained for MHC class I
(A to C; blue) or MHC class II (D and E; blue) as well as with phalloidin (A to E; red), visualizing actin. MCMV-infected cells which are situated distal (A
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PLoS Pathogens | www.plospathogens.org 8 August 2011 | Volume 7 | Issue 8 | e1002214infection (Fig. 7A), indicating that the strict requirement for CD4
T cells to control SG MCMV infection no longer holds in absence
of MCMV-encoded MHC class I immune evasion genes.
Consistent with the notion that CD8 T cells become major
contributors for control of SG MCMV infection in absence of
MHC class I immune evasion genes, CD8 T cell depletion resulted
in significantly impaired control of Dm04Dm06Dm152 MCMV
replication in the absence of CD4 T cells (Fig. 7B).
Discussion
In this study we unravel the underlying mechanisms of the
unique requirement for CD4 T cells to control MCMV replication
in the SG. We show that CD4 T cells control MCMV replication
in the SG by exerting direct antiviral effector functions via IFNc
secretion and not by providing helper functions to CD8 T cells or
B cells. While robust CD8 T cell responses were detected in
presence or absence of CD4 T cells in the SG, they were unable to
control MCMV replication due to the exquisite efficiency of
MCMV to downregulate MHC class I expression on infected
AGECs. In absence of MCMV-encoded MHC class I immune
evasion genes, CD8 T cells gained ability to control SG MCMV
infection also in absence of CD4 T cells.
However, in the absence of antiviral active CD4 T cells, B cells
and antibodies can contribute to control viral replication in the SG
on the long term, as infectious virus was eventually cleared in
CD4
-/- mice in all organs examined as opposed to MHCII
-/- mice.
One major difference between MHCII
-/- and CD4
-/- mice is that
the latter strain is able to mount isotype-switched antibody
responses [35,36]. MCMV-binding IgG and neutralizing antibod-
Figure 6. Cross-presenting APCs are absent in SG tissue. (A) Spleen cells and SG resident leukocytes from naı ¨ve or 4 week MCMV infected
mice were stained for I-A
b, CD11c, CD8a, CD4 or CD103 and B220. Left plots are gated on B220 negative cells and stained for I-A
b and CD11c, right
plots are gated on B220
2, MHC class II
+, CD11c
+ cells and stained for CD4 respectively CD103 and CD8a. Frequencies of gated cells among the parent
population are indicated. B) Total numbers of total CD11
+ I-A
b+ B220
2 (upper diagram) or CD11
+ I-A
b+ B220
2 CD8a
+ CD4
2 (lower diagram) DCs
resident in the spleen (black bar) or APCs in the SG (open bar) are shown for different time points post MCMV infection. C) DCs were isolated four
weeks post MCMV infection from spleen (left column) or APCs from the SG (right column) and pulsed with VLPs cross-linked to either the LCMV-
derived gp33 (upper left plots) or to gp61 (upper right plots) peptides or pulsed with the peptide (lower plots). 10
5 naı ¨ve CFSE-labeled gp33-specific
CD8 T cells (P14) or naı ¨ve CFSE-labeled gp61-specific CD4 T cells (Smarta) were added to equal numbers of splenic DCs or SG derived APCs. After 5
days of incubation, CFSE dilution was analyzed by gating on P14 or Smarta cells. One representative example of three individual experiments is
shown.
doi:10.1371/journal.ppat.1002214.g006
and D) or in proximity (B and E) to cell infiltrates were analyzed. Expression of MHC class I on uninfected AGECs is shown in C. Arrows point out weak
MHC class I or MHC class II expression on AGECs. Confocal images were taken with 100 times magnification. Scale bar indicates 10 mm. One
representative picture of a minimum of 10 is shown.
doi:10.1371/journal.ppat.1002214.g005
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-/- mice, but
were completely absent in MHCII
-/- animals (Fig. S6 and Text
S1). As MCMV-specific antibodies were previously shown to
inhibit viral dissemination during MCMV infection [12,37], they
are likely to be responsible for late differences in MCMV control
observed between MHCII
-/- and CD4
-/- mice.
In vitro, IFNc and TNFa can exert strong and synergistic
inhibition of MCMV replication in fibroblasts [38]. Systemic in
vivo neutralization of IFNc and TNFa in CD8 T cell depleted
MCMV infected BALB/c mice or in MCMV-infected lethally
irradiated mice transferred with MCMV-primed splenocytes
resulted in decreased MCMV control [6,7]. Thus, CD4 T cells
were suggested to act via secretion of IFNc and TNFa to limit viral
replication in the SG. However, in these studies, unlike ours, there
was no formal proof that CD4 T cells themselves and no other
cells secrete those cytokines. We were able to show for the first
time that CD4 T cells exert direct antiviral mechanisms by
producing IFNc and to a much lower extent - if at all - via TNFa
production or perforin-mediated effector mechanisms. At this
point we cannot formally exclude that CD4 T cells might interact
with other cells which then produce TNFa, thereby leading to
control of viral replication in the SG. However, our observation
that lytic MCMV replication is not controlled in chimeric mice
which specifically lack IFNcR expression on non-hematopoietic
cells would rather argue against a pivotal role of additional
effectors including TNFa.
It was proposed that NK-like cells might synergize with CD4 T
cells to control viral replication in the SG [4], due to the fact that
mice depleted of NK cells by anti-NK1.1 or anti-asialoGM1
antibodies showed increased viral titers in the SG [11,39,40,41].
Our data does not exclude a synergism between CD4 T and NK
cells, we can only conclude that a potential NK-CD4 T cell
interaction is unlikely to be mediated via IFNc. Further, the NK
cell compartment in the SG was not affected by the absence of
Figure 7. MCMV control in the SG in presence or absence of viral immune evasion genes. (A) B6, CD4
-/- or MHCII
-/- mice were infected
with MCMV-Dm04Dm06Dm152 or its parental BAC-derived virus (MCMV wt) and SG virus titers were determined 28 days post infection. (B) B6 and
CD4
-/- mice were depleted of CD8 T cells and infected with MCMV-Dm04Dm06Dm152 or its parental BAC-derived virus (MCMV wt) and SG virus titers
were determined 28 days post infection. Combined data of two independent experiments is shown. (* p,0.05, ** p,0.01, *** p,0.001, 2-tailed
unpaired student’s t-test).
doi:10.1371/journal.ppat.1002214.g007
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deficient animals, absolute numbers were comparable to wild type
mice and we were unable to detect any differences in NK cell
function between MHCII
-/- and B6 mice (Fig. S7 and Text S1).
Furthermore, SG-resident NK cells were recently shown to have
functional deficits and peripheral NK cells appear to be poorly
recruited to the SG during MCMV infection [42]. Finally, in
contrast to many reports demonstrating a role for NK cells in
limiting early MCMV replication [11,39,40,41,43], a recent study
showed a negative impact of NK cells on MCMV control due to
curtailed MCMV-specific T cell responses [44].
Why then is IFNc secreted by CD4 T cells so crucial to control
MCMV in the SG whereas IFNc production by other immune
cells such as CD8 T cell or NK cells is insufficient? Different
reasons could account for this: a) other immune cells might not
produce IFNc in the SG; b) CD4 T cells but no other IFNc-
producing cells migrate into close proximity of infected cells; c)
CD4 T cells might enable other immune cells to migrate to
infected cells; d) CD4 T cells, in contrast to CD8 T cells, might
recognize directly infected cells; e) antigens might not be presented
directly on infected cells but on bystander APCs that are unable to
cross-present and hence to activate CD8 T cells.
We show here evidence for the last scenario as both MCMV-
specific CD8 as well as CD4 T cells from the SG were able to
secrete IFNc, total numbers of IFNc
+ CD8 T cells exceeded by far
total numbers of IFNc
+ CD4 T cells, CD8 T cells were localized at
the same sites as CD4 T cells in the SG, the cellular composition of
the infiltrates were not changed in absence of CD4 T cells, most
directly infected cells in the SG were MHC negative and SG-
resident APCs were capable of processing and presenting
particulate antigen on MHC class II but not MHC class I
molecules. Importantly, we have no evidence for direct infection of
SG APCs, at least at the time points analyzed (Fig. 5 and data not
shown). Furthermore, we found some MHC class I and II positive
CD11c
+ cells within densely populated leukocyte infiltrates in the
SG which displayed discrete inclusion of cargo derived from
MCMV-infected cells, suggestive of phagocytes which had taken
up remnants of MCMV-infected AGECs.
Our observations that we only rarely detected MHC class I and
II molecules on directly infected AGECs stands in line with
findings that MCMV down-regulates very efficiently MHC
molecules, albeit this has mostly been shown in vitro for infected
fibroblasts, macrophages and dendritic cells [25,26,27,28,29]. In
fact our study demonstrates for the first time that MCMV can
indeed suppress surface expression of MHC complexes on AGECs
in vivo as well. MCMV expresses several gene products, so called
immune-evasins, that impair antigen presentation on MHC class I
molecules (reviewed by [29]). Interestingly, genetic deletion of
these immune-evasins resulted in increased MCMV immune
control specifically in the SG in a CD8 T cell dependent manner
in BALB/c mice [25], suggesting that MCMV expressed immune-
evasins are particularly potent in AGECs compared to cells of
other tissues. We corroborated and extended this observation by
showing that CD4 T cells were dispensable for MCMV control in
the SG in the absence of the virus-encoded m04, m06 and m152
immune-evasins. Up to date we were not able to study MHC class
I expression on AGECs infected with Dm04Dm06Dm152 MCMV
as the mutant strain currently available does not express GFP. In
future experiments we will generate a GFP expressing
Dm04Dm06Dm152 MCMV strain to address this open question.
In summary, the results of our study strongly support a model in
which virus-specific CD4 T cells but not CD8 T cells control viral
replication in the SG, thereby eventually curtailing horizontal
transmission (Fig. 8): In infected AGECs MCMV immune-evasins
inhibit trafficking of MHC class I molecules to the cell surface and
shut down the induction of MHC class II expression. MCMV
antigens released by the infected cells or remnants of infected cells
are taken up by local APCs which are unable to cross-present
particulate antigens but able to process and present on MHC class
II, thereby selectively inducing MCMV-specific CD4 T cells to
secrete IFNc. IFNc binds to its receptors present on infected cells
or / and on adjacent cells and exerts its antiviral function by
interfering with viral replication or rendering cells resistant for
subsequent MCMV infection.
Material and Methods
Ethics statement
This study was carried out in in strict accordance to the
guidelines of the animal experimentation law (SR 455.163; TVV)
of the Swiss Federal Government. The protocol was approved by
Cantonal Veterinary Office of the canton of Zurich, Switzerland
(Permit number 145/2008). All surgery was performed under
isoflurane anesthesia and animals were treated pre- and post-
surgically from day-1 to day+7 with the analgesic Buprenorphine.
All efforts were made to minimize suffering.
Mice, in vivo T cell depletion and peptides
C57BL/6, MHCII
-/- [45], CD4
-/- [46], CD8
-/-, B6.129P-Igh-
J
tm1Cgn (JHT) [47], IFNc
-/- (Charles River Laboratories), TNFa
-/-
(B6.129-TNF
tm1Ljo, [48]), PKOB [49] and IFNcR-deficient mice
were kept under specific pathogen free (SPF) conditions and were
infected intravenously with 10
6 plaque forming units (PFU) of
MCMV-Dm157, MCMV wt, MCMV-D04D06D152, MCMV-
Dm157-luciferase, or 5610
5 PFU MCMV-Dm157-GFP between 6
and 12 weeks of age. For CD8 T cell depletion, mice were injected
i.p. with 0.2 mg of purified anti-mouse CD8 monoclonal antibody
(YTS 169.4, [50]) 3 and 1 days before infection and then weekly.
The MCMV-derived M45aa985-993 and M38aa316-323 as well as
the LCMV-derived gp33 and gp61 peptides were purchased from
NeoMPS (Strasbourg, France). Production of a crude lysate of
MCMV infected cells was previously described [8]. Production
and purification of VLP-gp33 (HBcAg-p33) and VLP-gp61
(HBcAg-p33) was previously described [51].
Generation and characterization of bone marrow
chimeras
CD4
-/- mice were irradiated (950 rad c) and reconstituted with
a 1:1 mixture of bone marrow from CD4
-/- and CD4
-/- or IFNc
-/-
or TNFa
-/- or PKOB or C57BL/6 mice. In other experiments,
irradiated IFNcR
-/- or C57BL/6 recipients were reconstituted
with bone marrow of IFNcR
-/- or C57BL/6 mice.
Viruses
Generation of the recombinant MCMV-Dm157 (lacking the
m157 gene of MCMV) was previously described [8]. The m157-
deficient MCMV mutant expressing the luciferase gene was a kind
gift of Dr. M. Mach (Erlangen, Germany) [16]. The MCMV
mutant expressing green fluorescent protein (GFP) under the m157
promoter was described before [52] as well as MCMV-
Dm04Dm06Dm152 [34]. MCMV was propagated on mouse
embryonic fibroblasts (MEFs) and viral titers were determined
using plaque forming assays as described in [53].
In vivo bioluminescence imaging
Shaved mice were injected intravenously with 0.5 mg D-
luciferin in 200 mL PBS and immediately anaesthetized using
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was recorded over a 300-second integration period by a cooled
CCD camera system (IVIS Imaging System 200 Series, Caliper
Life Sciences AG, Oftringen, Switzerland). Anesthesia was
maintained during imaging by nose cone delivery of the
anesthetic. Relative intensities of transmitted light from the in
vivo bioluminescence were represented as pseudocolor imaging.
Antibodies
PE-conjugated peptide-MHC class I tetrameric complexes were
generated as previously described [54]. The following monoclonal
antibodies were either purchased from BD Pharmingen (Allschwil,
Switzerland) or from BioLegend (Lucerna Chem AG, Luzern,
Switzerland) and used for stainings: anti-CD8 (FITC, PerCP,
APC, PacificBlue, APC-Cy7), anti-CD4 (PE, PerCP, PacificBlue),
anti-IFNc (APC), anti-B220 (PE-Cy7), anti-Ly6C (FITC), CD11b
(PerCP), anti-CD11c (APC), anti-I-A
b (PE).
Cell stimulation, immunofluorescent staining and
analysis
Lymphocytes were isolated from spleen, lung, liver and SG as
previously described [55]. Cells were surface stained with directly
labeled Abs or peptide-MHC class I tetramer complexes followed
by erythrocyte lysis. For intracellular cytokine stainings, CD8 T
cells were stimulated with 1 mg/ml peptide and CD4 T cells with
10 mg/ml cell lysate in the presence of 10 mg/ml brefeldin A
(Sigma-Aldrich) at 37uC for 6 h. Cell surface staining was done as
described above, followed by fixation and permeabilization using
500 ml of FIX/Perm solution (FACSLyse diluted to 2x concen-
tration and 0.05% Tween 20) for 10 min at room temperature.
Cells were washed and stained with directly labeled Abs against
IFNc and TNFa. Multiparameter flow cytometric analysis was
performed using a FACS LSRII flow cytometer (BD, Allschwil,
Switzerland) with FACS DIVA software (BD, Allschwil, Switzer-
land). List mode data were analyzed using FlowJo software
(Treestar, San Carlos, CA).
Immunofluorescence microscopy
SG were isolated from infected animals, fixed for 1 h in PBS
containing 4% PFA at 4uC and incubated overnight in PBS
containing 20% sucrose, followed by tissue embedding in O.C.T.
compound (Sakura, Torrance, CA), snap-freezing in liquid N2 and
storing at 280uC. Cryosections of 16 mm thickness were prepared,
completely air-dried for 2 to 6 hours before recovery by a brief
rinse in PBS. Sections were blocked (PBS with 10% FCS) for one
hour. Primary antibody (CD4 (clone YTS191.1), CD8 (clone
YTS156), CD11c (BD Pharmingen), I-A
b (BioLegend), MHC class
I (Santa Cruz)) was added in staining buffer (1% mouse serum in
PBS) for one hour before extensive washing with PBS. Incubation
with secondary antibodies (anti-hamster IgG (Cy3/Cy5), Phalloi-
Figure 8. Virus-specific CD4 but not CD8 T cells control MCMV replication in the salivary gland. Surface expression of MHC class I and II is
effectively suppressed in infected acinar glandular epithelial cells (AGECs), thereby inhibiting direct recognition by MCMV-specific CD8 and CD4 T
cells. Phagocytic APCs situated in close proximity to virus-infected cells take up MCMV antigens, either in from of defective viral particles or apoptotic
bodies of infected cells, and present MCMV-derived peptide antigens on MHC class II molecules to CD4 T cells but not to CD8 T cells due to their
inability to cross-present particulate antigens. Activated MCMV-specific CD4 T cells secrete IFNc which consequently binds to its receptor on the cell
surface of the infected cell as well as on adjacent AGECs. Activation of IFNcR signaling cascade on adjacent cells induces an antiviral state, rendering
them resistant to MCMV replication and IFNc signaling in infected cells leads to the termination of MCMV replication.
doi:10.1371/journal.ppat.1002214.g008
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purchased from Sigma-Aldrich) containing DAPI (Sigma-Aldrich)
diluted in staining buffer lasted one hour, followed by extensive
washing and fixation with 1% PFA and mounting with
VectaShield (Vector Laboratories, Burlingame, CA). Samples
were viewed and analyzed with an inverted confocal microscope
(Axiovert 200, Carl Zeiss, Inc.), equipped with an oil-phase
contrast objective (Plan Neofluar, Carl Zeiss, Inc.), an ultraview
confocal head (PerkinElmer, location) and a krypton argon laser
(643-RYB-A01, Melles Griot). Data analysis was done with
Velocity (Improvision).
Cross-presentation assay
One month post MCMV infection four to five spleens and SG
were digested using Liberase TL Research Grade (Roche,
Rotkreuz, Switzerland) and DNaseI according to manufacturer’s
instruction, except that SG tissue was dissociated previous to
digestionandinbetween two incubationperiodsof20minutes.DCs
from the spleen and APCs from the SG were purified with CD11c
MACS beads according to manufacturer’s instruction, pulsed with
either 1 mg/ ml VLPs or 10
28 M peptide for 1 hour at 37uC. After
intensive washing, APCs were counted and purity was determined
by FACS analysis. Equal numbers of splenic DCs and SG APCs
(varying inter experimentally between 0.5 to 1610
5 cells) were
added to 10
5 TCR transgenic CD8 or CD4 T cells previously
labeled with CFSE (Invitrogen, Basel, Switzerland; end concentra-
tion 2 mM) and incubated for 5 days. CD8 and CD4 T cells were
MACS-purified from spleens of Ly5.1
+ P14 or Ly5.1
+ Smarta
transgenic mice, respectively. 5 days later cells were labeled with
antibodies against CD4, CD8 and Ly5.1 and analyzed by FACS.
Supporting Information
Figure S1 Virus titer kinetics in B6, CD4
-/-, MHCII
-/-
and JHT mice. B6, CD4
-/-, MHCII
-/- or JHT mice were
infected with MCMV and viral titers were determined by plaque
assay up to 120 days post infection in spleen, liver, kidney and SG.
One of three independent experiments is shown.
(EPS)
Figure S2 Helper functions exerted by CD4 T cells are
dispensable for MCMV control. A) 4 weeks and B) 8 weeks
post infection viral titers in the SG were compared between
CD8
-/-, JHT, MHCII
-/- and wild type mice (B6). Statistical
analysis was done using unpaired t-test. n.s. not significant,
*p ,0.05
(EPS)
Figure S3 B cells, CD11b
+ and NK cells infiltrate the
infected SG tissue independent of CD4 T cells. SGs were
isolated three weeks post infection from B6 (left two columns) or
MHCII-/- (right two columns) mice infected with a GFP-
expressing MCMV mutant. Cryosections of SGs were counter-
stained with either anti-B220 (A; red) to detect B cells, anti-CD11b
(B; red), anti-asialoGM1 (C; red) to detect NK cells and CD11c (A
to C; blue). MCMV-bearing AGECs (green) situated distal to
immune infiltrates (first and third column) and immune infiltrates
(second and fourth column) are displayed. Confocal images were
taken with 20 times magnification. Scale bar indicates 100 mm.
One representative picture of a minimum of 10 is shown.
(TIF)
Figure S4 Composition of cellular infiltrate in the SG of
infected mice. B6, CD4
-/- or MHCII
-/- mice were infected with
MCMV. 28 days post infection leukocytes were isolated from the
SG and pooled in between experimental groups. Total numbers of
lymphocytes, CD8 T cells, CD4 T cells, B cell, NK cells (CD49
+,
TCRb
2), NKT cells (CD49
+, TCRb
+), CD11c
+ cells and CD11b
+
cells were determined by flow cytometry.
(EPS)
Figure S5 MHC class I and II expression on CD11c
+
cells with focal GFP inclusions. Three weeks post MCMV-
GFP infection, SG sections isolated from B6 mice were stained for
MHC class I (A; blue) or MHC class II (B; blue) molecules as well
as with phalloidin (A and B; red), visualizing actin. Few CD11c
+
cells with focal GFP inclusions (arrows) were found which
expressed MHC class I (A) or MHC class II (B). Confocal images
were taken with 40 times magnification. Scale bar indicates
10 mm. One representative picture of minimum 3 is shown.
(TIF)
Figure S6 MCMV-specific antibody response. B6, CD4
-/-,
MHCII
-/- or JHT mice were infected with MCMV and MCMV-
specific antibodies were longitudinally determined by ELISA (A)
or by neutralization assay (B). Titers refer to 50% neutralization
capacity. One of three independent experiments is shown.
(EPS)
Figure S7 NK cell frequencies, activation and function
in presence or absence of CD4 T cells. B6 and MHCII
-/-
mice were infected with MCMV and frequencies of NK cells were
determined in the spleen and SG at the indicated time points post
infection by flow cytometry. IFNc production within NK cells was
assessed directly ex vivo as well as the percentage of activated NK
cells (identified by CD69 expression). One of two independent
experiments is shown.
(EPS)
Text S1 Supporting information.
(DOC)
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